---
title: "QUANTUM PHARMA GROUP LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c61609af-574b-55a3-8eba-68502a7bf9b3
json: https://whiteintel.dev/api/public/dossier/c61609af-574b-55a3-8eba-68502a7bf9b3
identifier: oo:GB-COH-06775418
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# QUANTUM PHARMA GROUP LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06775418`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c61609af-574b-55a3-8eba-68502a7bf9b3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c61609af-574b-55a3-8eba-68502a7bf9b3  

## Ownership & control

### Owners / controllers

- **QUANTUM PHARMA 2014 LIMITED** (beneficial owner) — https://whiteintel.dev/entity/4bd899ca-789c-5ba8-9e61-50675195a2be
- **QUANTUM PHARMA 2014 LIMITED** (beneficial owner) — https://whiteintel.dev/entity/4bd899ca-789c-5ba8-9e61-50675195a2be

### Holdings / subsidiaries

- **LAMDA PHARMA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/29bfc23b-3406-5f8a-b493-13846b89535b
- **PROTOMED LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/4d5e2298-93d9-5b6b-b1b4-a3c05dae6521
- **QUANTUM PHARMACEUTICAL LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c488a0d1-550f-5f25-ac3b-ad733e534518
- **LAMDA PHARMA LIMITED** (beneficial owner) — https://whiteintel.dev/entity/29bfc23b-3406-5f8a-b493-13846b89535b
- **PROTOMED LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4d5e2298-93d9-5b6b-b1b4-a3c05dae6521
- **QUANTUM PHARMACEUTICAL LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c488a0d1-550f-5f25-ac3b-ad733e534518

### UBO chain (walk to the ultimate owner)

A **11-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06775418`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2008-12-17
- **Registered office:** 25 Bedford Square, Bloomsbury, London, WC1B 3HH, United Kingdom
- **SIC:** 70100

### Officers

- ADAIR, Richard Edward — secretary · appointed 2024-04-30
- BROOKSBANK, Stephanie Jane — director · British · appointed 2026-04-28
- PALING, Richard John — director · British · appointed 2018-06-30
- SETHI, Varun — director · Indian · appointed 2026-01-22
- EDGE, Ian — secretary · British · appointed 2009-01-14 · resigned 2010-01-29
- MILLER, Amanda — secretary · appointed 2017-11-02 · resigned 2023-01-16
- SUCH, Martin John — secretary · appointed 2010-01-29 · resigned 2015-03-03
- SWINHOE, Craig Robert — secretary · appointed 2015-02-24 · resigned 2017-11-02
- HAMMONDS SECRETARIES LIMITED — corporate secretary · appointed 2008-12-17 · resigned 2009-01-14
- BARKER, Michael Denis — director · British · appointed 2015-06-18 · resigned 2016-10-05
- BRYANT, David John — director · British · appointed 2018-06-30 · resigned 2024-01-26
- CHARTON, Jerome Marie Joseph — director · Swiss · appointed 2024-04-30 · resigned 2025-10-08
- CROSSLEY, Peter Mortimer — director · British · appointed 2008-12-17 · resigned 2009-01-14
- EDGE, Ian — director · British · appointed 2009-01-14 · resigned 2010-09-08
- ENGELEN, Thomas — director · Dutch · appointed 2012-10-30 · resigned 2014-12-11
- FISHER, Brian James — director · British · appointed 2015-02-24 · resigned 2017-12-22
- GARNER, John — director · British · appointed 2013-12-17 · resigned 2014-12-11
- GILBERT, Jane — director · British · appointed 2014-11-25 · resigned 2014-12-11
- MARTIN, Stephen Jeremy — director · British · appointed 2015-02-24 · resigned 2017-11-01
- MASSEY, Nicola Jayne — director · British · appointed 2015-11-09 · resigned 2017-01-31

### Beneficial owners (Persons with Significant Control)

- [Quantum Pharma 2014 Limited](https://whiteintel.dev/entity/4bd899ca-789c-5ba8-9e61-50675195a2be) — significant influence or control · corporate PSC · United Kingdom — since 2016-12-17

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06775418
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06775418

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **QUANTUM PHARMA GROUP LIMITED** — https://whiteintel.dev/entity/c61609af-574b-55a3-8eba-68502a7bf9b3 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **QUANTUM PHARMA GROUP LIMITED**. Human view: https://whiteintel.dev/entity/c61609af-574b-55a3-8eba-68502a7bf9b3 · Structured JSON: https://whiteintel.dev/api/public/dossier/c61609af-574b-55a3-8eba-68502a7bf9b3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._